High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque

Microbes and Infection

Volumn 8, Issue 11, 2006, Pages 2587-2598

  Lewinsohn, David M ^a,b,c   Tydeman, Ian S ^a   Frieder, Marisa ^a,b   Grotzke, Jeff E ^a,b   Lines, Rebecca A ^d   Ahmed, Sheela ^b   Prongay, Kamm D ^c   Primack, Steven L ^b   Colgin, Lois M A ^e   Lewis, Anne D ^e   Lewinsohn, Deborah A ^b,c,d  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CT scanning; Macaque; Tuberculosis

Indexed keywords

ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOPSY; BACTERIAL INFECTION; BACTERIAL STRAIN; BLOOD; BRONCHOSCOPE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LUNG LOBE; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RADIOGRAPHY; RHESUS MONKEY; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HISTOCYTOCHEMISTRY; LUNG; MACACA MULATTA; MYCOBACTERIUM TUBERCULOSIS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS;

MACACA MULATTA; MYCOBACTERIUM TUBERCULOSIS; PRIMATES;

EID: 33750200737     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.07.007     Document Type: Article

References (25)

1. Global Tuberculosis Control: Surveillance, Planning, Financing. Who Report 2002, Geneva, Switzerland, 2002.
2. Ginsberg A.M. A proposed national strategy for tuberculosis vaccine development. Clin. Infect. Dis. 30 Suppl. 3 (2000) S233-S242
3. McMurray D.N., and Bartow R.A. Immunosuppression and alteration of resistance to pulmonary tuberculosis in guinea pigs by protein undernutrition. J. Nutr. 122 Suppl. 3 (1992) 738-743
4. Fox J.G., Murphy J.C., Esser R.E., Delmonico F.L., and Cosimi A.B. Tuberculosis outbreak in rhesus monkeys immunosuppressed with antithymocyte globulin. J. Med. Primatol. 7 5 (1975) 264-273
5. Zumpe D., Silberman M.S., and Michael R.P. Unusual outbreak of tuberculosis due to Mycobacterium bovis in a closed colony of rhesus monkeys (Macaca mulatta). Lab. Anim. Sci. 30 2 Pt 1 (1980) 237-240
6. Good R.C. Biology of the mycobacterioses. Simian tuberculosis: Immunologic aspects. Ann. N.Y. Acad. Sci. 154 1 (1968) 200-213
7. Barclay W.R., Anacker R.L., Brehmer W., Leif W., and Ribi E. Aerosol-induced tuberculosis in subhuman primates and the course of the disease after intravenous BCG vaccination. Infect. Immun. 2 (1970) 574-582
8. Walsh G.P., Tan E.V., dela Cruz E.C., Abalos R.M., Villahermosa L.G., Young L.J., Cellona R.V., Nazareno J.B., and Horwitz M.A. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat. Med. 2 4 (1996) 430-436
9. Capuano III S.V., Croix D.A., Pawar S., Zinovik A., Myers A., Lin P.L., Bissel S., Fuhrman C., Klein E., and Flynn J.L. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71 10 (2003) 5831-5844
10. Langermans J.A., Andersen P., van Soolingen D., Vervenne R.A., Frost P.A., van der Laan T., van Pinxteren L.A., van den Hombergh J., Kroon S., Peekel I., Florquin S., and Thomas A.W. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc. Natl. Acad. Sci. U.S.A. 98 20 (2001) 11497-11502
11. Snewin V.A., Gares M.P., Gaora P.O., Hasan Z., Brown I.N., and Young D.B. Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect. Immun. 67 9 (1999) 4586-4593
12. Manning C.H., and Heise E.R. Establishment and characterization of Macaca fascicularis lymphoblastoid cell lines. J. Med. Primatol. 21 1 (1992) 15-23
13. + T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction. J. Immunol. 165 2 (2000) 925-930
14. Dillon D.C., Alderson M.R., Day C.H., Lewinsohn D.M., Coler R., Bement T., Campos-Neto A., Skeiky Y.A., Orme I.M., Roberts A., Steen S., Dalemans W., Badaro R., and Reed S.G. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect. Immun. 67 6 (1999) 2941-2950
15. Lewinsohn D.A., Lines R.A., and Lewinsohn D.M. Human dendritic cells presenting adenovirally expressed antigen elicit Mycobacterium tuberculosis-specific CD8+ T cells. Am. J. Respir. Crit. Care Med. 166 6 (2002) 843-848
16. Lewinsohn D.M., Lewinsohn D.A., and Grotzke J.E. TB vaccines at the turn of the century: Insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease. Semin. Respir. Infect. 18 4 (2003) 320-338
17. Langermans J.A., Doherty T.M., Vervenne R.A., van der Laan T., Lyashchenko K., Greenwald R., Agger E.M., Aagaard C., Weiler H., van Soolingen D., Dalemans W., Thomas A.W., and Andersen P. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85b and esat-6. Vaccine 23 21 (2005) 2740-2750
18. Geng E., Kreiswirth B., Burzynski J., and Schluger N.W. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study. JAMA 293 22 (2005) 2740-2745
19. Hirsch C.S., Toossi Z., Othieno C., Johnson J.L., Schwander S.K., Robertson S., Wallis R.S., Edmonds K., Okwera A., Mugerwa R., Peters P., and Ellner J.J. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180 6 (1999) 2069-2073
20. + T cells preferentially recognize heavily infected cells. Am. J. Respir. Crit. Care Med. 168 11 (2003) 1346-1352
21. Carrara S., Vincenti D., Petrosillo N., Amicosante M., Girardi E., and Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin. Infect. Dis. 38 5 (2004) 754-756
22. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67 8 (1999) 3980-3988
23. + T cells during Mycobacterium tuberculosis infection. J. Immunol. 167 12 (2001) 6991-7000
24. + T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J. Exp. Med. 200 11 (2004) 1479-1489
25. Schwander S.K., Torres M., Sada E., Carranza C., Ramos E., Tary-Lehmann M., Wallis R.S., Sierra J., and Rich E.A. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J. Infect. Dis. 178 5 (1998) 1434-1445